The Linacre Quarterly
Volume 70

Number 1

Article 2

February 2003

The Ethics of Mandatory HIV Testing of All Pregnant Women
Peter A. Clark

Follow this and additional works at: https://epublications.marquette.edu/lnq

Recommended Citation
Clark, Peter A. (2003) "The Ethics of Mandatory HIV Testing of All Pregnant Women," The Linacre
Quarterly: Vol. 70: No. 1, Article 2.
Available at: https://epublications.marquette.edu/lnq/vol70/iss1/2

The Ethics of Mandatory HIV Testing of
All Pregnant Women
by
Peter A. Clark, S.J., Ph.D.

Dr. Clark holds the John McShane Chair in Ethics
at Saint Joseph's University in Pittsburgh.

There is a healthy debate raging within the medical community concerning
the ethics of mandatory human immunodeficiency virus (HIV) testing of
all pregnant women. In the early 1990s, prior to perinatal preventative
treatments that are available today, an estimated 1,000 to 2,000 infants
were born with HIV infection each year in the United States. l In 1994,
clinical trials showed that HIV-infected women could reduce the risk of
transmitting the virus to their babies by as much as two-thirds through
administration of zidovudine (ZDV or AZT) during pregnancy, labor and
delivery, and by giving the newborns AZT for the first six weeks after
birth. 2 The results of these clinical trials fueled the debate for mandatory
testing of all pregnant women. In 1994, the Public Health Service issued
guidelines for using AZT during pregnancy, and in 1995, published
guidelines for routinely counseling all pregnant women about HIV and
offering them an HIV test. As health care professionals incorporated these
guidelines into their clinical practice, the number of children with
perinatally acquired AIDS dropped 43% by 1996.3 Encouraged by these
statistics, Congress mandated a study and review of the federal guidelines
by a committee of the Institute of Medicine, an affiliate of the National
Academy of Sciences, concerning HIV testing of all pregnant women . On
October 14, 1998, the committee issued its report and recommended
making HIV testing part of routine prenatal care. The committee believed
that mandatory HIV testing of all pregnant women would save additional
lives, especially among the minority communities, and more than pay for
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itself by cutting the cost of caring for infected children, which can amount
to tens of thousands of dollars annually for each child. 4 The committee
was convinced that the benefits of mandatory testing, which are prevention
of perinatal HIV transmission and better care for infected mothers and their
children, greatly outweigh the burdens of possible violation of the
mother's privacy and a possible decrease in the willingness to seek
counseling about HIV and AIDS. The potential of saving lives and the
cost-benefit analysis has only added fuel to this current ethical controversy.
The intended purpose of this article is three-fold: first, to examine the
scientific evidence regarding the status of perinatal HIV prevention; second,
to give an ethical analysis of the arguments for and against mandatory HIV
testing of all pregnant women; and third, to determine if the federal
guidelines should be revised to include mandatory HIV testing of all
pregnant women and if this position is based on solid ethical principles.
Status of Perinatal HIV Prevention

In the United States, as of December 1997, 641,086 Americans had
been reported with AIDS and 350,000 of them had died. The year after, the
CDC estimated that as many as 650,000 to 900,000 Americans were living
with HIV and at least 400,000 infections occur each year.s In 1996,
according to the CDC, the estimated number of adults diagnosed with
AIDS-defining opportunistic illnesses decreased for the first time, from
61 ,300 estimated cases in 1995 to 57,200 in 1996. Also in 1996, for the
first time, the estimated deaths among persons with AIDS declined to
39,200 from 50,700 in 1995. 6 This decline in both the incidence of new
cases and the mortality rate in adults can be attributed to the introduction of
the three classes of antiretroviral drugs: nucleoside analogue antiretrovirals
(AZT, ddI, ddC, 3TC, d4T),1 the non-nucleoside reverse transcriptase
inhibitors (nevirapine, delavirdine, efavirer),8 and the protease inhibitors
(crixivan, fortovase, norvir, viracept, and others).9 Even more significant
are the facts concerning the perinatal transmission of HIY. In the United
States, if HIV-infected women are not treated with AZT in pregnancy,
roughly 25 percent of their infants will be HIV infected when born. If they
are treated with AZT, the figure falls to 8 percent or lower. Between 1992
and 1996, perinatally acquired AIDS cases declined 43 % in the United
States. In 1997, this trend continued with a 30% decline. lo Currently in the
United States, roughly 8 percent of all infants born to HIV-infected women
- fewer than 500 a year - are born infected. I I In the March 31, 1999 issue of
The New England Journal of Medicine, data revealed that "a Caesarian
alone reduces by half the risk of AIDS transmission during birth. An
infected woman who has both a Caesarean ami treatment with AZT has
only a 2% chance of infecting her child." 12 The success of the AZT
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regi men on preg nant wo men and now the new data on the effects of
Caesa ri an birth has given new hope to those women infected with HIV and
to their c hildren."
The HI V infec tion rate in c hildre n is closely linked with the HIV
infec ti on rate in wo me n. According to the CDC, "HIV transmission from
mothers to child during pregnancy, labor and delivery or by breast-feeding
has acco unted fo r 9 L pe rcent of all AIDS cases reported among United
States c hildren."' -l Stati sti cs show th at women of color and their children
have always been and co ntinue to be di sproporti onately affected by the
HIVep idem ic. In 1997. of the total 13, 105 AIDS cases reported among
U.S. women. 10,458 (80 ~ ) were among Afri can-A me ri can and Hi spanic
women Y Of the 473 chil dren reported with AIDS in 1998,402 (85%)
we re African-A me ri can a nd Hi spani c. ' 6
The reasons fo r the
di sproportionate infection rate a mo ng wome n of colo r is due not onl y to
inadequ ate perinatal HIV preventi on efforts, and inadequate access and
utili zation of prenatal care offered to wome n of color, but also to the sense
of m i tru st that both Afri can- Ameri cans and Hi spani cs have for the
medical establi shme nt.
Th is m istru st, especiall y by Afri can- Americans, can be attributed to
the events surround ing the Tuskegee Syphilis Study, whi ch was sponsored
by the United States Public Health Service from J932 to 1972. 17 However,
after careful research and analys is, it appears that thi s study is but a marker
fo r a more seri ous problem regarding rac ist attitudes and stereotypes that
has ex isted for centuri es in the medical pro fession. Hi stori an Al an Brandt
argues th at the medi cal professio nals and researchers who directed and
dev ised the Tu skegee Syphili s Study accepted the mainstream assumptions
regard ing blac ks. 'There ca n be little doubt that the Tuskegee researchers
regarded their subj ects as less than hum an. As a result, the ethi cal canons
of experim enting on hum an subj ects were completely di sregarded."'8 The
major impact of the Tuskegee story was that it authenti cated a hi stori callybased pattern of medical mistreatment that has been well-known to the
African- Ameri can communi ty th rough their own oral folkloric tradition.
Thi s pattern shows th at Afri can- Ameri cans, and fo r that matter all
min orities, were viewed as inhere ntl y inferi or by the medi cal profession
and pu bli c health age ncies. T hi s has led to the lingerin g suspicion that
medi cal profess ionals are not out to help minoriti es, but to use them as
guinea pigs. '9 The influe nce of rac ism in the medi cal profession and a
general di sregard toward th ose who are poor and vulne rabl e by the federal
governme nt has contribu ted to the " legacy of mi stru st" in the minority
co mmunities and has had far-reaching consequences .20 One major
conseq uence has been that women of color are suspicious of any
government-sponsored programs that advocate testing or ex perimental
medicati ons. The res ult ha . bee n th at a 1995 study th at analyzed data on
4
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approximately one-sixth of all HIV-exposed children born in the United
States found that only about half (53%) received the benefit of a full AZT
treatment regimen (for the mother during pregnancy and delivery and for
the infant for the first six weeks after birth). According the CDC. "the
main reason for babies not having the advantage of therapy was that more
than one-fourth of the mothers (26%) did not get prenatal care."2 1 The
majority of these mothers were women of color and a major reason for
their lack of prenatal care is their suspicion of the medical establishment.
Mandatory HIV testing of all pregnant women would not only save
countless lives but would also conserve a large percentage of medical
resources. The CDC estimates that without intervention, a 25 % mother-toinfant transmission rate would result in the birth of an estimated 1,750
HIV-infected infants annually in the United States, with a lifetime medical
cost of $282 million. Researchers estimate that the annual cost of perinatal
prevention is $67.6 million. This investment prevents 656 HIV infections
and saves $105 .6 million in medical care costs alone, for a net cost-savings
of $38.1 million annuallyY However, now with the new findings
regarding the use of AZT and the effects of Caesarean birth, the number of
lives saved and medical costs saved will increase.
Critics of mandatory HIV testing for all pregnant women focus on
three distinct areas. First, there are those critics who believe the focus of
testing and treatment should be on the high-risk population. The problem
with this is that HIV knows no boundaries . Women not in the high-risk
population may also have been exposed unbeknownst to them . To single
out specific groups, such as women of color, within the population could
lead to discrimination and may force those most in need of HIV counseling,
testing, and treatment to take less advantage of prenatal care than they do at
present. It would also further the suspicion women of color feel toward the
medical establishment. Second, some critics argue that if HIV testing
becomes mandatory for all pregnant women it will eliminate or at least
decrease the counseling that is associated presently about HIV and AIDS.
Mildred Williamson, president of the AIDS Policy Center for Children ,
Youth and Families, stated, "Women must fully understand what an HIV
test is, and the implications of a positive or negative result. It is not enough
to simply inform women that they are being tested for HIV, and put the
burden on them to ask questons."23 There is no reason to believe that there
would be a decrease or an elimination of counseling on HIV and AIDS .
Health care professionals have a professional and an ethical obligation to
explain all tests and procedures to their patients as part of the principle of
informed consent. To say that once mandatory testing becomes a federal
guideline such counseling will cease to exist or the amount of counseling
will decrease seems to question the professionalism and integrity of
physicians. Third, some critics are concerned about protecting the privacy
February, 2003
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of prospective mothers, especially regarding the documentation of HIV
test results. The American Medical Association has adopted key principles
regarding the patient's right to privacy and the confidentiality of medical
records.
1)

2)

3)

That there exists a basic right of patients to pri vacy of their
medical information and records, and that this right should be
explicitl y acknowledged;
That pati ents' pri vacy should be honored unless waived by
the patient in a meaningful way (i.e. , informed, noncoercive)
or in rare instances of strong ly countervailing public interest
and
That information di sclosed should be limited to that
information, portion of the medical record, or abstract
necessary to fulfill the immedi ate and specific purposeY

It is possible that the pri vacy of a pregnant woman might be violated.
However, with various guidelines and safeguards in place, that medical
records cannot be used without the informed consent of the patient, and
with additional legi slation being proposed to protect the privacy of HIV
and AIDS patients, these concerns can be addressed in a way that would
offer reasonable protection.
The practical concerns regarding mandatory testing of all pregnant
women appear to be surmountable. From an ethical standpoint, however,
thi s is a far more complex and controversial issue. Both sides in thi s
debate appear to have legitimate concerns that they believe can be
supported ethically. It must be determined which arguments are more
convincing from an ethical point of view in the face of such a devastating
crisis.
Ethical Analysis

The ethical controversy surrounding the debate over mandatory HIV
testing of all pregnant women has taken on a sense of urgency because
every day we delay in implementing this policy more children wi ll be born
infected with HIV and more women, unaware that they are HIV-infected,
will not only go untreated but may also infect others through sexual contact
or intravenous drug injection. Proponents of mandatory HIV testing, such
as Dr. Marie McCormick, director of Maternal and Child Health at the
Harvard School of Public Health, argue that "we have the tools to prevent
HIV infection in newborns and we must make sure they are available to
everyone."25 The benefits of mandatory testing in preventing HIV
infection to newborns and better care for infected mothers and their
children can all be achieved at a cost to the country that is far below what
6
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we spend today on treatment for infected individuals. This utilitarian
argument is quite convincing, considering the devastating effect the AIDS
epidemic has had on the allocation of medical resources both nationally
and internationally. Time is of the essence for this public health issue and
concern for the "common good" must be a priority. Opponents argue that
mandatory testing will violate the basic human right of privacy. The term
" right to privacy" encompasses "our right to live our personal lives as we
see fit, to control what may be done to our own bodies, and to limit what
information others may obtain about our personal affairs."26 Opponents
argue that a pregnant woman 's privacy could also be violated because there
are not adequate safeguards in place to keep the results of such testing
confidential. Therefore, mandatory testing could violate their privacy
twice - first by testing against their will, and then by giving others access
to the results. Finally, opponents argue that this issue brings to light the
reality of the slippery slope argument. If we allow for mandatory testing of
all pregnant women today, why not for all people tomorrow? What about
mandatory testing for drugs, alcohol, genetic disorders , etc? The ethical
ramifications are far-reaching.
Society, in general, has always recognized that in our complex world
there is the possibility that we may be faced with conflict situations that
leave us with two options, both of which are nonmoral evilsY The timehonored ethical principle that has been applied to these situations is called
the principle of the lesser of the two evils. "When one is faced with two
options, both of which involve unavoidable (nonmoral) evil, one ought to
choose the lesser evil."28 According to bioethicist Richard McCormick,

S.1.,

The concomitant of either course of action is harm of some sort.
Now in situations of thi s kind. the rule of Christian reason, if we are
governed by the ordo bonorum, is to choose the lesser evil. This
general statement is, it would seem, beyond debate: for the only
alternati ve is that in conflict situations we should choose the greater
evil, which is patentl y absurd. This mean s that all concrete rules and
distinctions are subdsidiary to this and hence valid to the extent that
they actually convey to us what is factually the lesser evil. ... Now, if
in a conflict situation one does what is, in balanced Christian
judgment (and in thi s sense "objectively"), the lesser evil , his
intentionality must be said to be integral. It is in this larger sense that
I would attempt to read Thomas Aquinas 's statement that moral acts
"recipiunt speciem secundum id quod intenditur." Thus the basic
category for conflict situations is the lesser evil, or avoidable/
unavoidable evil, or proportionate reason. 19
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Therefore, in a conflict situati on, an individual may directly choose to do a
nonmoral evil (violating a person's autonomy, privacy, confidentiality) as a
means to a truly proportionate good end (preservation and protection of
human life) :lo
The principle of the lesser of two evils is applicable to the issue of
mandatory HIV testin g of all pregnant women because one is faced with
two options, both of which in volve unavoidable nonmoral evils. On the
one hand, failure to allow for mandatory testing of all pregnant women
would result in hundreds of innocent HIV-infected infants being born
yearl y, and hundreds of women remaining unaware of their HIV infection
and thus unable to seek earl y treatment and to protect others from the
possible transmission of this lethal disease. In addition, there is the loss of
millions of dollars in medic al care costs annually as scientific data has
show n. On the other hand, allowing for mandatory testing would violate a
preg nant woman 's ri ght to privacy by testing against her will, and also
could possibly violate her privacy by giving others possible access to the
resul ts.
The direct intention of mandatory HIV testing of all pregnant women
is to protect and preserve human life and to encourage social support,
professional counseling and medical care. Studies have shown that the
hi ghest incidence of AIDS cases among women reported in the United
States is among women of color. The direct intention of mandatory testing
is to protect and preserve the lives of the most vulnerable, that is, the poor
and the minorities, by stoppin g the spread of HI V transmission to innocent
newborns and seeki ng immediate medical attention for infected mothers.
However, in the process of protecting and preserving human life, which
benefits the co mmon good, the pregnant woman 's autonomy is violated.
One would hope that all pregnant women would voluntarily agree to HIV
testing, but this is not always possible and has not been a reality. The
linchpin for resolving which option is the lesser of two evils rests on
whether or not there is a proportionate reason for allowing mandatory
testing of all pregnant women.
Proportionate reason refers to a specific value and its relation to all
elements (including nonmoral evils) in the action .3 1 The specific value in
all owing for mandatory testing is to protect and preserve human life by
preventing the lethal transmi ssion of HIV to innocent newborns and
getti ng immediate medical treatment for the infected mothers. The
nonmoral ev il, which is the result of trying to achieve this value, is the
violation of the pregnant woman 's ri ght to privacy. The ethical question is
whether the value of protecting and preserving human life outweighs the
nonmoral evil of violating a woman 's right to privacy? To detennine if a
proper re lationship exists between the specific value and the other

8

Linacre Quarterly

elements of the act, ethicist Richard McCormick, S.J. proposes three
criteria for the establishment of proportionate reason :
1)
2)
3)

The means used will not cause more harm tha n necessary to
achieve the va lue.
No less harmful way ex ists to protect the value.
The mean s used to achieve the value will not undermine ir.'2

The application of McCormick's criteria to mandatory HN testing of
pregnant women supports the argument that there is a proportionate reason
for allowing this testing . First, scientific data has proven th at mandatory
HIV testing of all pregnant women will save the li ves of hundreds of
innocent children and will prolong the lives of those determined to be
infected if immediate medical treatment is begun. Voluntary HIV testing
of pregnant women has helped lower the number of children with
perinatally acquired AIDS by 43 %. In addition, the CDC has estimated
this would yield a net savings in medical costs and resources of $38. 1
million annually.}} With the present state of health care costs skyrocketin g,
this savings would certainly benefit the common good ." It is apparent that
the means used will cause more good than harm, and will cause less harm
than necessary to protect and save lives.
Second, at present, there does not appear to be an alternative that is
as effective as mandatory testing. It is true that other means ex ist, such as
the federal guidelines that call for routine counseling of all pregnant women
about HIV and offering them an HIV test. The result has been a 43 percent
decrease in perinatal HIV transmi ssion, which is an impressive decline.
With additional education and more access to and utilization of prenatal care
these statistics may even improve. However, the CDC statistics have shown
that the highest rate of AIDS infections among women in the United States
is among women of color. The barriers preventing women of color from
seeking prenatal care and thus voluntarily agreeing to HIV testing are great.
There is the "legacy of mistrust" which exists among the minority
communities toward the medical establishment, the health care di sparities
which presently exist among the minority population, and the lack of
adequate HIV education. Despite the success of the present federal
guidelines, even the American Medical Association (AMA) supports the
position that "there should be mandatory HIV testing of all pregnant women
and newborns with counseling and recommendations for appropriate
treatments. "3~ Opponents to mandatory testing believe these baniers can be
eliminated with education and increased access to prenatal care. However,
as we wait for this to be accomplished, thou sands of children will become
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HIV infected, women who are HIV infected will be unaware of this fact
and not seek appropriate treatment, and because they are unaware of their
status, they have the potential to pass this disease onto many others.
Voluntary HIV testing is less harmful , but it does not protect and preserve
the value of human life.
Third, mandatory testing does not undermine the value of human
life. One can argue convincingly that the intention of mandatory HIV
testing of pregnant women is to save human lives. Mandatory testing will
not only save the lives of countless newborns but will allow thousands of
women who are unaware of their HIV status to begin treatments that may
save their lives and the lives of others they could possibly infect in the
future. In the process, there is the possibility that punitive effects could
result from mandatory testing. If the federal guidelines are changed, will
they require mandatory reporting of HIV test results?
The fear of discrimjnation is a real threat. There have been cases in
the past when individuals have lost employment and medical insurance
when employers and/or insurers have learned of an employee's HIV positive
test results. However, proponents argue that mandatory testing results could
be kept confidential with the proper procedures in place. The 1996 Health
Insurance Portability and Accountability Act requires that the U.S.
Department of Health and Human Services recommend to Congress a means
for protecting individually identifiable information and establishing
penalties for wrongful disclosure of such confidential data. The Department
of Health and Human Services made such privacy recommendations to
Congress for review on September II , 1997. 35 The New York Times
reported that as of January 1999, six bills relating to medical records were
privately circulating in Congress. J6
The purpose of mandatory testing is to save lives and it has been
proven scientifically to be effective. This is a public health issue that must
be addressed because innocent lives are being lost. It seems clear that there
is a proportionate reason for the federal government to change its guidelines
regarding mandatory HIV testing of all pregnant women. Such testing
contributes to the well-being of the pregnant mothers, to the well-being of
their newborns, to those who could be infected through contact with the
undiagnosed, and by lowering medical costs to society as a whole over time.
Therefore, it is ethically justified under the principle of proportionate reason
for the federal government to change the guidelines regarding mandatory
HIV testing for all pregnant women in the United States. Mandatory testing
of all pregnant women is the lesser of two evils because the greater good is
promoted in spite of the potential for evil consequences.
Finally, from an ethical perspective, opponents argue that allowing
mandatory HIV testing of pregnant women will set a legal precedent which
could have dire consequences in the future. The slippery slope argument
10
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suggests that if particular precedents are accepted, then certain
consequences will follow as a matter of due course. By setting federal
guidelines that allow for mandatory testing in the case of all pregnant
women, what would stop the federal government from establishing similar
guidelines in the future for mandatory HIV testing for all people or for
genetic di seases? Certainly the same ethical arguments could be used to
justify both types of mandatory testing. Physical harm could be averted ,
treatments could be initiated sooner rather than later, and preventive care is
certainly less costly than waiting for the di sease to manifest itself. This is
a valid argument, but it is an argument that could be used in any scenario.
With every medical treatment there is always the potential for abuse. But
because the potential is present does not mean it has to become a reality.
Being aware of the possibility of abuse can be the impetus for safeguards
which can be put in place to prevent similar abuses in the future. Because
something can be abused does not mean it should be avoided. Instead, it
should be an opportunity to address such weaknesses to avoid future
negative ramifications.
Conclusion
I believe that mandatory HIV testing of all pregnant women in the
United States is both a necessary and a vital part of a broader
comprehensive strategy for preventing the spread of AIDS. After reviewing
all the pertinent scientific data it is clear that mandatory HIV testing of all
pregnant women would save thousands of human lives - mothers, newborns
and others who could be infected as a result of these women not being
aware of their HIV status. It is apparent that voluntary HIV testing has
made some valuable inroads in decreasing perinatal HIV transmission, but
the statisti cs showing the disproportionate rate of HIV infection among
women of color are not very promi sing. Numerous barriers presently exist
that cause women of color not to have access to or utilize prenatal care. To
eliminate these barriers will take years, if elimjnation is possible at all. In
the process, countless newborns will become HIV infected and infected
mothers will fail to seek appropriate treatment and may even spread the
disease to others, all because they are unaw are of their HIV status. If we as
a nation believe that the life of every person is sacred and should be treated
with dignity and respect, especially the lives of the most vulnerable, then
we must support what we believe is the greater good to protect and
preserve human life. Thi s does not mean that we should not continue to
explore new ways to encourage voluntary HIV testing of all people. It
does mean that if this is the best method available at the present time to
protect the lives of innocent people, we must utilize it to its fullest capacity.
It appears that the opponents to mandatory testing are say ing the right to
February, 2003

II

privacy and autonomy is a greater good than the preservation of human
life. The AIDS virus is a runaway epidemic and as Dr. Peter Piot, head of
the United Nations AIDS Program has stated, the time is now for us to
embrace not only a new realism but also a new sense of urgency if we are
going to combat this dreaded killer. 37 We cannot allow fears of future
ramifications and an absolute sense of privacy to stand in the way of
fighting this lethal disease. Human lives hang in the balance. If the
protection and preservation of human life is a priority in this country, then
it is time to allow for mandatory HIV testing of all pregnant women, before
it is too late for those who are the most vulnerable.

Postscript
On July IS, 1999, The New York Times reported that the drug
nevirapine had cut the risk of mother-to-child transmission of HIV to 13%
from 25 % for the standard course of AZT in developing countries.
Nevirapine, a drug used in combination "cocktail" treatments, has been
marketed in the United States for treatment of HIV since 1996. The more
practical therapy comes from substituting one marketed drug, nevi rapine,
for the standard drug, AZT. The treatment calls for both a mother and her
infant to take nevirapine just one time - a mother takes the pill during
labor, and her baby is fed the drug as a syrup once during the first three
days of life. The cost of the two doses of nevirapine is $4 , compared with
$268 for the AZT regimen now used in developing countries. American
and Ugandan researchers are planning another study to see if it would be
more effective to give nevirapine to mother and infant for longer periods.
Also, a continuing study in the United States and Europe aims to determine
if adding nevi rapine to standard regimens will further lower the
transmission rate of HIV from mother to child. 38
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